• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    47.31 Down 0.35(0.73%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:47.66
    Open:47.86
    Bid:42.00 x 100
    Ask:122.35 x 1500
    1y Target Est:56.25
    Beta:-1.77
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:47.02 - 48.01
    52wk Range:12.63 - 49.49
    Volume:656,557
    Avg Vol (3m):913,762
    Market Cap:4.04B
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXDown 0.73%4.04B
    ABTDown 0.22%73.56B
    LLYUp 1.52%91.22B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):205.93
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-0.86
    Quarterly EPS Est (Jun-15) :-0.29
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):5.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback